Table 2.

Effect of the tested drugs on Kidney Hypertrophic Index in alloxan-induced diabetic rats

Kidney Hypertrophic Index
Groups	KHI ( g/g * 1000 )
Normal control group	4.555 ± 0.423
Diabetic control group	6.6125 ± 0.57*
Diabetic group treated with bromocriptine	4.7475 ± 0.33#
Diabetic group treated with cabergoline	4.81 ± 0.49#
Diabetic group treated with sarpogrelate	5.90 ± 0.27
Diabetic group treated with bromocriptine + sarpogrelate	4.715 ± 0.61#
Diabetic group treated with cabergoline + sarpogrelate	4.46 ± 0.48#

Values shown are means ± SEM; n = 6 rats per group. * P < 0.05, significantly different from the normal control group; # P < 0.05, significantly different from the diabetic control group